<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art560.dtd?><?SourceDTD.Version 5.6.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_XPRO100312 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?FILEgr3 jpg ?><?FILEgr4 jpg ?><?FILEgr5 jpg ?><?FILEgr6 jpg ?><?FILEfx1 jpg ?><?FILEfx2 jpg ?><?FILEfx3 jpg ?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">STAR Protoc</journal-id><journal-id journal-id-type="iso-abbrev">STAR Protoc</journal-id><journal-title-group><journal-title>STAR Protocols</journal-title></journal-title-group><issn pub-type="epub">2666-1667</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7856476</article-id><article-id pub-id-type="pii">S2666-1667(21)00019-8</article-id><article-id pub-id-type="doi">10.1016/j.xpro.2021.100312</article-id><article-id pub-id-type="publisher-id">100312</article-id><article-categories><subj-group subj-group-type="heading"><subject>Protocol</subject></subj-group></article-categories><title-group><article-title>Protocol for hit-to-lead optimization of compounds by auto <italic>in silico</italic> ligand directing evolution (AILDE) approach</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Mei</surname><given-names>Longcan</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="fn1" ref-type="fn">5</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Wu</surname><given-names>Fengxu</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="fn1" ref-type="fn">5</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>Hao</surname><given-names>Gefei</given-names></name><email>gefei_hao@foxmail.com</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="aff3" ref-type="aff">3</xref><xref rid="fn2" ref-type="fn">6</xref><xref rid="fn3" ref-type="fn">7</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><contrib contrib-type="author" id="au4"><name><surname>Yang</surname><given-names>Guangfu</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="aff4" ref-type="aff">4</xref></contrib><aff id="aff1"><label>1</label>Key Laboratory of Pesticide &#x00026; Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University, Wuhan 430079, China</aff><aff id="aff2"><label>2</label>International Joint Research Center for Intelligent Biosensor Technology and Health, Central China Normal University, Wuhan 430079, China</aff><aff id="aff3"><label>3</label>State Key Laboratory Breeding Base of Green Pesticide and Agricultural Bioengineering, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Research and Development Center for Fine Chemicals, Guizhou University, Guiyang 550025, China</aff><aff id="aff4"><label>4</label>Collaborative Innovation Center of Chemical Science and Engineering, Tianjin 300072, China</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author <email>gefei_hao@foxmail.com</email></corresp><fn id="fn1"><label>5</label><p id="ntpara0010">These authors contributed equally</p></fn><fn id="fn2"><label>6</label><p id="ntpara0015">Technical contact</p></fn><fn id="fn3"><label>7</label><p id="ntpara0020">Lead contact</p></fn></author-notes><pub-date pub-type="pmc-release"><day>01</day><month>2</month><year>2021</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><day>19</day><month>3</month><year>2021</year></pub-date><pub-date pub-type="epub"><day>01</day><month>2</month><year>2021</year></pub-date><volume>2</volume><issue>1</issue><elocation-id>100312</elocation-id><permissions><copyright-statement>&#x000a9; 2021 The Author(s)</copyright-statement><copyright-year>2021</copyright-year><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><title>Summary</title><p>Hit-to-lead (H2L) optimization is crucial for drug design, which has become an increasing concern in medicinal chemistry. A virtual screening strategy of auto <italic>in silico</italic> ligand directing evolution (AILDE) has been developed to yield promising lead compounds rapidly and efficiently. The protocol includes instructions for fragment compound library construction, conformational sampling by molecular dynamics simulation, ligand modification by fragment growing, as well as the binding free energy prediction.</p><p>For complete details on the use and execution of this protocol, please refer to <xref rid="bib11" ref-type="bibr">Wu et&#x000a0;al. (2020)</xref>.</p></abstract><abstract abstract-type="graphical" id="abs0015"><title>Graphical abstract</title><fig id="undfig1" position="anchor"><graphic xlink:href="fx1"/></fig></abstract><abstract abstract-type="author-highlights" id="abs0020"><title>Highlights</title><p><list list-type="simple" id="ulist0010"><list-item id="u0010"><label>&#x02022;</label><p id="p0010">Detailed instructions are given for ligand modification by fragment growing</p></list-item><list-item id="u0015"><label>&#x02022;</label><p id="p0015">Conformational sampling is performed by molecular dynamics simulation</p></list-item><list-item id="u0020"><label>&#x02022;</label><p id="p0020">Binding free energy of a protein-ligand complex is computationally evaluated</p></list-item></list></p></abstract><abstract abstract-type="teaser" id="abs0025"><p>Hit-to-lead (H2L) optimization is crucial for drug design, which has become an increasing concern in medicinal chemistry. A virtual screening strategy of auto <italic>in silico</italic> ligand directing evolution (AILDE) has been developed to yield promising lead compounds rapidly and efficiently. The protocol includes instructions for fragment compound library construction, conformational sampling by molecular dynamics simulation, ligand modification by fragment growing, as well as the binding free energy prediction.</p></abstract><kwd-group id="kwrds0010"><title>Subject areas</title><kwd>Bioinformatics</kwd><kwd>Protein biochemistry</kwd><kwd>Structural biology</kwd></kwd-group></article-meta></front><body><sec id="sec1"><title>Before you begin</title><p id="p0025">Auto <italic>in silico</italic> ligand directing evolution (AILDE) is an effective approach to rapidly explore the structure-activity relationship for H2L optimization (<xref rid="bib11" ref-type="bibr">Wu et&#x000a0;al., 2020</xref>). AILDE is utilized to optimize a hit compound by minor chemical modifications on its scaffold. Minimal increases or losses for the binding efficiency of ligand could be obtained by these modifications. Hence, this method can help us for the exploration of the chemical space around a hit compound and promote the optimization of the hit compound into more drug-like lead compounds. <xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref> shows the workflow of AILDE. AILDE is based on molecular dynamics (MD) simulation complemented with one-step free energy perturbation (FEP) (<xref rid="bib2" ref-type="bibr">Hao et&#x000a0;al., 2015</xref>; <xref rid="bib10" ref-type="bibr">Wu et&#x000a0;al., 2018</xref>). MD simulation is firstly performed on the protein-hit complex. The equilibrated conformational ensemble is then collected. The hit ligand in each conformation is modified to new ligand with substitution using the fragment library. The binding free energy changes between protein-hit and hit analogs are calculated. New leads are finally determined based on the rank of the binding affinity changes.<fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Workflow of the AILDE method</p><p>Once an initial protein-hit complex structure is provided, AILDE will conduct the hit-to-lead optimization according to the following steps: (1) molecular dynamics simulation: this allow to simulate the structural flexibility of the protein-hit complex; (2) collecting the conformational ensemble: adequately collect the representative conformations of a protein-hit complex; (3) generating the hit analogues: a fragment growing based method is utilized to convert a hit to analogue compounds. The conformations of protein-analogues complex are obtained from the representative conformations of the protein-hit complex; (4) binding free energy change: comparing the binding free energy of protein-hit and protein-analogues complexes. Identifying the potential lead compounds according to the rank of the binding free energy changes.</p></caption><graphic xlink:href="gr1"/></fig></p><p id="p0030">We should provide a productive computational environment for the usage of AILDE. We need a high performance computer with a Unix-based operating system to perform this protocol. A graphics processing unit (GPU) equipment is advised to be used to accelerate the process of molecular dynamics simulation. The prerequisite software (in the <xref rid="sec2" ref-type="sec">materials and equipment</xref> section) is freely available on the corresponding websites. The detail introduction about the installation is provided in their user manuals. These software are utilized in different procedures. We download the source code of AILDE at <ext-link ext-link-type="uri" xlink:href="https://github.com/fwangccnu/AILDE" id="intref0010">https://github.com/fwangccnu/AILDE</ext-link>. After configuration of the computational environment, we prepare the input data according to the following steps.</p><sec id="sec1.1"><title>Preparing the input structure file of the protein complex with a hit ligand</title><p id="p0035"><disp-quote><p><inline-graphic xlink:href="fx2.gif"/><bold>Timing: &#x0223c;15&#x000a0;min</bold></p></disp-quote><list list-type="simple" id="olist0010"><list-item id="o0010"><label>1.</label><p id="p0040">Download the structure file of our interest protein complex with a hit ligand from RCSB Protein Data Bank (PDB) (<ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/" id="intref0015">https://www.rcsb.org/</ext-link>). For example, search the PDB ID of <ext-link ext-link-type="uri" xlink:href="pdb:2P3B" id="intref0020">2P3B</ext-link> in PDB database, and obtain the result of the crystal structure of the subtype B wild type HIV protease complexes with TL-3 inhibitor. And save the PDB format structure file.</p></list-item><list-item id="o0015"><label>2.</label><p id="p0045">Open the structure file by Chimera software, keep the hit ligand and its direct interacting protein chain and delete all the irrelative molecules, and save as a processed PDB format structure file. <xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>A shows the example of deleting the irrelative atoms by Chimera software. A detail document about the usage of Chimera is available on the website (<ext-link ext-link-type="uri" xlink:href="https://www.cgl.ucsf.edu/chimera/docindex.html" id="intref0025">https://www.cgl.ucsf.edu/chimera/docindex.html</ext-link>).<fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>The complex structure file preparation</p><p>(A) Illustration of selecting and deleting the irrelative atoms from the complex by Chimera software.</p><p>(B) Example of renaming amino acids according to their protonated states and adding a &#x0201c;TER&#x0201d; record. The positions of proton in different protonated states are highlighted in red: HID represents histidine with hydrogen on the delta nitrogen, HIE on the epsilon nitrogen, and HIP on both nitrogens.</p><p>(C) Illustration of the structure preparation by the Dock Prep module in Chimera. This module can perform some complex operations, such as deleting solvent and isolated ions, keeping only the conformation with highest occupancy, repairing missing atoms, and adding hydrogen atoms.</p></caption><graphic xlink:href="gr2"/></fig></p></list-item><list-item id="o0020"><label>3.</label><p id="p0050">Text edit the processed structure file. Rename MSE residues as MET, and rename HIS as HID, HIE, or HIP based on the protonated states (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>B). And add a &#x0201c;TER&#x0201d; record to indicate that the chains are not physically connected to each other. If there are alternative conformations of the residues, keep only the highest occupancy. These operations can be conducted by Chimera software (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>C).</p></list-item></list><disp-quote><p><bold><italic>Note:</italic></bold> Alternatively, we can obtain the complex structure of a protein with a hit ligand by molecular docking method (<xref rid="bib6" ref-type="bibr">Meng et&#x000a0;al., 2011</xref>).</p></disp-quote><disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> It requires the complex structure file to strictly abide by a standard PDB format, and a description about PDB format file is accessed at <ext-link ext-link-type="uri" xlink:href="http://www.wwpdb.org/documentation/file-format-content/format33/v3.3.html" id="intref0030">http://www.wwpdb.org/documentation/file-format-content/format33/v3.3.html</ext-link>.</p></disp-quote></p></sec></sec><sec id="sec8"><title>Key resources table</title><p id="p0455"><table-wrap position="float" id="undtbl1"><table frame="hsides" rules="groups"><thead><tr><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr><td colspan="3"><bold>Deposited data</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>Three-dimensional structure</td><td>RCSB Protein Data Bank (PDB)</td><td>PDB: <ext-link ext-link-type="uri" xlink:href="pdb:2P3B" id="intref0090">2P3B</ext-link></td></tr><tr><td>ZINC</td><td>(<xref rid="bib4" ref-type="bibr">Irwin and Shoichet, 2005</xref>)</td><td><ext-link ext-link-type="uri" xlink:href="http://zinc12.docking.org/browse/subsets/" id="intref0095">http://zinc12.docking.org/browse/subsets/</ext-link></td></tr><tr><td>FDB-17</td><td>(<xref rid="bib9" ref-type="bibr">Visini et&#x000a0;al., 2017</xref>)</td><td><ext-link ext-link-type="uri" xlink:href="https://gdb.unibe.ch/tools/" id="intref0100">https://gdb.unibe.ch/tools/</ext-link></td></tr><tr><td>PADFrag</td><td>(<xref rid="bib12" ref-type="bibr">Yang et&#x000a0;al., 2018</xref>)</td><td><ext-link ext-link-type="uri" xlink:href="http://chemyang.ccnu.edu.cn/ccb/database/PADFrag/index.php/help/download" id="intref0105">http://chemyang.ccnu.edu.cn/ccb/database/PADFrag/index.php/help/download</ext-link></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Software and algorithms</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>AILDE source code</td><td>This study</td><td><ext-link ext-link-type="uri" xlink:href="https://github.com/fwangccnu/AILDE" id="intref0110">https://github.com/fwangccnu/AILDE</ext-link></td></tr></tbody></table></table-wrap></p></sec><sec id="sec2"><title>Materials and equipment</title><sec id="sec2.1"><title>Equipment</title><p id="p0055"><list list-type="simple" id="ulist0015"><list-item id="u0025"><label>&#x02022;</label><p id="p0060">Computer: a computational workstation installed with proper software listed below is required.</p></list-item><list-item id="u0030"><p id="p0065">List of hardware of the computational workstation:</p></list-item><list-item id="u0035"><p id="p0070">CPU: Intel Core i5-6400 3.3GHz 4-core processor</p></list-item><list-item id="u0040"><p id="p0075">Memory: Kingston KVR16N11/8 8GB DDR3-1600</p></list-item><list-item id="u0045"><p id="p0080">GPU: GeForce GTX 1060 3GB</p></list-item><list-item id="u0050"><p id="p0085">Storage: Western Digital WD10EZEX 1TB</p></list-item></list></p></sec><sec id="sec2.2"><title>Software</title><p id="p0090"><list list-type="simple" id="ulist0020"><list-item id="u0055"><label>&#x02022;</label><p id="p0095">Chimera (version 1.13 or later, <ext-link ext-link-type="uri" xlink:href="https://www.cgl.ucsf.edu/chimera/" id="intref0035">https://www.cgl.ucsf.edu/chimera/</ext-link>)</p></list-item><list-item id="u0060"><label>&#x02022;</label><p id="p0100">OpenBabel (version 2.3.2 or later, <ext-link ext-link-type="uri" xlink:href="http://openbabel.org/wiki/Main_Page" id="intref0040">http://openbabel.org/wiki/Main_Page</ext-link>)</p></list-item><list-item id="u0065"><label>&#x02022;</label><p id="p0105">Python (version 2.7, <ext-link ext-link-type="uri" xlink:href="https://www.python.org/" id="intref0045">https://www.python.org/</ext-link>)</p></list-item><list-item id="u0070"><label>&#x02022;</label><p id="p0110">Amber and AmberTools (version 16, <ext-link ext-link-type="uri" xlink:href="https://ambermd.org/" id="intref0050">https://ambermd.org/</ext-link>)</p></list-item><list-item id="u0075"><label>&#x02022;</label><p id="p0115">Autogrow (<ext-link ext-link-type="uri" xlink:href="http://autogrow.ucsd.edu/" id="intref0055">http://autogrow.ucsd.edu/</ext-link>)</p></list-item><list-item id="u0080"><label>&#x02022;</label><p id="p0120">R package (version 3.0.0 or later, <ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/" id="intref0060">https://www.r-project.org/</ext-link>)</p></list-item><list-item id="u0085"><label>&#x02022;</label><p id="p0125">A molecular visualizing software for viewing the complex structures, such as VMD (<ext-link ext-link-type="uri" xlink:href="https://www.ks.uiuc.edu/Research/vmd/" id="intref0065">https://www.ks.uiuc.edu/Research/vmd/</ext-link>) or PyMOL (<ext-link ext-link-type="uri" xlink:href="https://pymol.org/2/" id="intref0070">https://pymol.org/2/</ext-link>).</p></list-item></list></p></sec></sec><sec id="sec3"><title>Step-by-step method details</title><sec id="sec3.1"><title>A fragment library construction</title><p id="p0130"><disp-quote><p><inline-graphic xlink:href="fx2.gif"/><bold>Timing: &#x0223c;3 h</bold></p></disp-quote><list list-type="simple" id="olist0015"><list-item id="o0025"><label>1.</label><p id="p0135">Create the three-dimensional structures of all fragments by Chimera software (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>). The fragments are used to link with the hit compound to generate the hit analogs (<xref rid="bib3" ref-type="bibr">Hoffer et&#x000a0;al., 2018</xref>). All the hydrogen atoms should be deleted in the fragment molecules, except the hydrogen atoms located at the linking point.<fig id="fig3"><label>Figure&#x000a0;3</label><caption><p>Construction of stereoscopic conformation of a fragment molecule</p><p>The Build Structure module in Chimera provides several ways to manipulate a molecular structure. This snapshot shows the procedure for building a benzene molecule.</p></caption><graphic xlink:href="gr3"/></fig></p></list-item></list></p><p id="p0140">Due to the fixed format of a PDB file, it is easy to do these by the scripts in batch mode. We can delete all the hydrogen atoms in a PDB file except the linking point of a hydrogen atom (serial number: <italic>id</italic>) by a line of bash command:<list list-type="simple" id="ulist0025"><list-item id="u0090"><p id="p0145">awk '{if ($NF&#x000a0;== "H" &#x00026;&#x00026; $2 != id) {} else {print}}' fragment_H.pdb &#x0003e; fragment_noH.pdb</p></list-item></list></p><p id="p0150">where <italic>id</italic> is the serial number of a hydrogen atom as the linking point, <italic>fragment_H.pdb</italic> is the pdb file of a fragment molecule with all hydrogen atoms, <italic>fragment_noH.pdb</italic> is the fragment molecule with only a hydrogen atom.</p><p id="p0155">For a large number of fragments, we just need to use the loop function to deal with each individual repeatedly:<list list-type="simple" id="ulist0030"><list-item id="u0095"><p id="p0160">for i in $(ls &#x02217;.pdb)</p></list-item><list-item id="u0100"><p id="p0165">do<list list-type="simple" id="ulist0035"><list-item id="u0105"><p id="p0170">fragname=$(basename ${i} .pdb)</p></list-item><list-item id="u0110"><p id="p0175">for j in $( awk '{if ($NF&#x000a0;== "H") {print $2}}' ${i})</p></list-item><list-item id="u0115"><p id="p0180">do<list list-type="simple" id="ulist0040"><list-item id="u0120"><p id="p0185">awk '{if ($NF&#x000a0;== "H" &#x00026;&#x00026; $2 != &#x0201c;&#x02018;${j}&#x02019;&#x0201d;) {} else {print}}' ${i} &#x0003e; ${fragname}_${j}.pdb</p></list-item></list></p></list-item><list-item id="u0125"><p id="p0190">done</p></list-item></list></p></list-item><list-item id="u0130"><p id="p0195">done</p></list-item></list></p><p id="p0200">We can save the above bash codes in a text file (for example: a file named <italic>del_H.sh</italic>) in the same directory as the fragment PDB files. And run the scripts by type the following in the command line:<list list-type="simple" id="ulist0045"><list-item id="u0135"><p id="p0205">bash del_H.sh</p></list-item></list></p><p id="p0210">The processed PDB files of fragments are generated in the directory.<list list-type="simple" id="olist0020"><list-item id="o0030"><label>2.</label><p id="p0215">Perform the conformational optimization on the fragment molecules by Chimera software.</p></list-item><list-item id="o0035"><label>3.</label><p id="p0220">Save the structure files of those processed fragment molecules in PDB format.</p></list-item></list><disp-quote><p><bold><italic>Note:</italic></bold> The fragment molecules can be download from public fragment databases (<xref rid="bib4" ref-type="bibr">Irwin and Shoichet, 2005</xref>; <xref rid="bib9" ref-type="bibr">Visini et&#x000a0;al., 2017</xref>; <xref rid="bib12" ref-type="bibr">Yang et&#x000a0;al., 2018</xref>). The related website links are available in the <xref rid="sec8" ref-type="sec">key resources table</xref>.</p></disp-quote></p></sec><sec id="sec3.2"><title>Preparing input parameter data</title><p id="p0225"><disp-quote><p><inline-graphic xlink:href="fx2.gif"/><bold>Timing: &#x0223c;5&#x000a0;min</bold></p></disp-quote></p><p id="p0230">Prepare an input parameter file, in which all the parameters for AILDE calculation are contained.<list list-type="simple" id="olist0025"><list-item id="o0040"><label>4.</label><p id="p0235">Create a parameter file which contains all the necessary parameters for AILDE protocol (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>). Mandatory parameters are &#x0201c;step,&#x0201d; &#x0201c;complex,&#x0201d; &#x0201c;ligand_name,&#x0201d; &#x0201c;ligand_charge,&#x0201d; &#x0201c;parallel,&#x0201d; &#x0201c;MDstart,&#x0201d; &#x0201c;MDend,&#x0201d; &#x0201c;mm_pbsa,&#x0201d; &#x0201c;md_request,&#x0201d; and &#x0201c;entropy.&#x0201d; Each parameter has a default value.<fig id="fig4"><label>Figure&#x000a0;4</label><caption><p>Preparing the input parameter file</p><p>(A) The snapshot of webpage for downloading the example parameter file at <ext-link ext-link-type="uri" xlink:href="https://github.com/fwangccnu/AILDE" id="intref0115">https://github.com/fwangccnu/AILDE</ext-link>.</p><p>(B) The content in the example parameter file.</p></caption><graphic xlink:href="gr4"/></fig></p></list-item><list-item id="o0045"><label>5.</label><p id="p0240">An example parameter file is provided in the AILDE source code (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>). A standard format must be followed to define the parameters. Among those parameters, the following three parameters should be adjusted according to actual situation:<list list-type="simple" id="olist0030"><list-item id="o0050"><label>a.</label><p id="p0245">complex: define the structure file name of the protein complex with hit ligand.</p></list-item><list-item id="o0055"><label>b.</label><p id="p0250">ligand_name: define the name of the hit ligand in the complex structure file.</p></list-item><list-item id="o0060"><label>c.</label><p id="p0255">md_request: define whether structural relaxation is performed on the newly obtained hit analogs-protein complex by molecular dynamics (MD) simulation.</p></list-item></list></p></list-item><list-item id="o0065"><label>6.</label><p id="p0260">Other parameters can be maintained as default value and the detail descriptions about these parameters are recorded in the template parameter file (<xref rid="sec6.1" ref-type="sec">Troubleshooting 1</xref>).</p></list-item></list><disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> The parameters should be accordant with the actual situations and abide by the format in the example parameter file.</p></disp-quote></p></sec><sec id="sec3.3"><title>Molecular dynamics simulation of the protein-hit complex</title><p id="p0265"><disp-quote><p><inline-graphic xlink:href="fx2.gif"/><bold>Timing: &#x0223c;3 h</bold></p></disp-quote></p><p id="p0270">In this stage, conformational sampling on the protein complex with hit ligand is conducted by molecular dynamics simulation (<xref rid="bib5" ref-type="bibr">Maximova et&#x000a0;al., 2016</xref>).<list list-type="simple" id="olist0035"><list-item id="o0070"><label>7.</label><p id="p0275">The topology and coordinate file for the solvated protein-hit complex is generated by <italic>tleap</italic> module in Amber program. Protein was parameterized by Amber ff14SB force filed and the hit compound molecule by the general Amber force field (GAFF). AM1-BCC charge was assigned for the hit compound by <italic>antechamber</italic> module in Amber. The complex system was then solvated in the cube box of the TIP3P water model with a distance of 10&#x000a0;&#x000c5; between the solute and box. The counter-ions (Cl<sup>&#x02212;</sup> or Na<sup>+</sup>) were then added to neutralize the solvated protein-hit system.</p></list-item><list-item id="o0075"><label>8.</label><p id="p0280">Three cycles of energy minimization are performed on the system by <italic>sander</italic> module in Amber program. Each cycle includes 5,000 steps of steepest descent, followed by 5,000 steps of conjugated gradient minimization with a final convergence criterion of 0.2&#x000a0;kcal&#x02219;mol<sup>&#x02212;1</sup>. The following shows a brief description about three cycles of energy minimization:<list list-type="simple" id="olist0040"><list-item id="o0080"><label>a.</label><p id="p0285">Cycle 1: the heavy atoms in protein and hit compound are restrained with an elastic constant of 50&#x000a0;kcal&#x02219;mol<sup>&#x02212;1</sup>&#x02219;&#x000c5;<sup>&#x02212;2</sup>. The water molecules, ions, and hydrogen atoms are allowed to move for relaxation.</p></list-item><list-item id="o0085"><label>b.</label><p id="p0290">Cycle 2: protein side-chains are also allowed to relax in this step. Only the heavy atoms in the backbone of the protein are restrained with an elastic constant of 50&#x000a0;kcal&#x02219;mol<sup>&#x02212;1</sup>&#x02219;&#x000c5;<sup>&#x02212;2</sup>.</p></list-item><list-item id="o0090"><label>c.</label><p id="p0295">Cycle 3: the whole system is minimized.</p></list-item></list></p></list-item><list-item id="o0095"><label>9.</label><p id="p0300">Molecular dynamics simulation is then performed on the protein-hit complex with the periodic boundary condition in the NPT ensemble. The detail steps are described as the following:<list list-type="simple" id="olist0045"><list-item id="o0100"><label>a.</label><p id="p0305">The solvated system is heated gradually from 0 to 298 K in the NVT ensemble during a period of 500 ps.</p></list-item><list-item id="o0105"><label>b.</label><p id="p0310">The heated system is equilibrated in the NPT ensemble during a period of 1&#x000a0;ns.</p></list-item><list-item id="o0110"><label>c.</label><p id="p0315">Production simulation at the temperature of 298 K and the pressure of 1 atm. The SHAKE algorithm is used to constrain all covalent bonds involving hydrogens. The particle mesh Ewald (PME) algorithm is used to calculate long-range electrostatic interactions and the short-range van der Waals (vdW) interactions is handled with a cutoff distance of 10&#x000a0;&#x000c5;. The integration of the equations of motion is conducted at a time step of 2 fs. Finally, 1&#x000a0;ns production simulation is performed and the structure snapshots are collected every 1&#x000a0;ps (<xref rid="sec6.3" ref-type="sec">Troubleshooting 2</xref>).</p></list-item></list></p></list-item><list-item id="o0115"><label>10.</label><p id="p0320">The fluctuations of the protein and hit compound are measured by root-mean-square deviations (RMSD) against their initial structures. The stability of the MD simulation is reflected by their RMSD values, which reveal the conformational changes during the time period of MD simulation. A plateau RMSD value means that the protein-hit complex is in the equilibration state, and that the simulation moves toward the stability status.</p></list-item></list></p></sec><sec id="sec3.4"><title>Collecting the conformational ensemble of protein-hit complex</title><p id="p0325"><disp-quote><p><inline-graphic xlink:href="fx2.gif"/><bold>Timing: &#x0223c;10&#x000a0;min</bold></p></disp-quote></p><p id="p0330">After the molecular dynamics simulation, we collected the representative conformations from the equilibrated simulation trajectories. Consideration of structural flexibility has an effect on the accuracy of binding free energy calculation. Predicting free energy changes using structural ensembles has better performance than that using static structures (<xref rid="bib1" ref-type="bibr">Benedix et&#x000a0;al., 2009</xref>).<list list-type="simple" id="olist0050"><list-item id="o0120"><label>11.</label><p id="p0335">50 snapshots are extracted from the last 1&#x000a0;ns simulation trajectory by the cpptraj module in Amber program.</p></list-item></list></p></sec><sec id="sec3.5"><title>Fragment growing to generate the hit analogs</title><p id="p0340"><disp-quote><p><inline-graphic xlink:href="fx2.gif"/><bold>Timing: &#x0223c;1 h</bold></p></disp-quote></p><p id="p0345">In this stage, AILDE generates hit analogs by linking the fragment molecules with the hit ligand in the initial protein complex (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>).<list list-type="simple" id="olist0055"><list-item id="o0125"><label>12.</label><p id="p0350">All fragment molecules in our fragment library are linked with the hit ligand by AutoGrow software.</p></list-item><list-item id="o0130"><label>13.</label><p id="p0355">The generated compounds with the protein are saved as protein-analogs complexes. The complex structures are relaxed by energy minimization via one of the following two strategies:<list list-type="simple" id="olist0060"><list-item id="o0135"><label>a.</label><p id="p0360">When the parameter &#x0201c;md_request&#x0201d; is set to &#x0201c;NO,&#x0201d; structural relaxation without molecular dynamics simulation will be performed. First, all the backbone atoms of protein and the ligand are restrained with an elastic constant of 50&#x000a0;kcal&#x02219;mol<sup>&#x02212;1</sup>&#x02219;&#x000c5;<sup>&#x02212;2</sup>. Then the whole system is minimized. Each of the two minimization steps includes 5,000 cycles of steepest descent and 5,000 cycles of conjugated gradient optimization with a convergence criterion of 0.2&#x000a0;kcal&#x02219;mol<sup>&#x02212;1</sup>.</p></list-item><list-item id="o0140"><label>b.</label><p id="p0365">When the parameter &#x0201c;md_request&#x0201d; is set to &#x0201c;YES,&#x0201d; structural relaxation with molecular dynamics simulation will be performed. The above two cycles of energy minimizations is performed. Then a short period of MD simulation is performed to relax the side-chain atoms.</p></list-item></list></p></list-item><list-item id="o0145"><label>14.</label><p id="p0370">All the structure snapshots of protein-hit complex are relaxed by the same strategy as mentioned above (<xref rid="sec6.5" ref-type="sec">Troubleshooting 3</xref>).</p></list-item></list><disp-quote><p><bold><italic>Note:</italic></bold> In our previous study (<xref rid="bib11" ref-type="bibr">Wu et&#x000a0;al., 2020</xref>), structural relaxation with molecular dynamics simulation may provide more accurate binding free energy results, but at the cost of more computing resources.</p></disp-quote><fig id="fig5"><label>Figure&#x000a0;5</label><caption><p>Lead compounds generation by fragment growing strategy</p><p>This illustrates the process of converting a hit compound to a lead compound by fragment linking with the former.</p></caption><graphic xlink:href="gr5"/></fig></p></sec><sec id="sec3.6"><title>Predicting free energy changes for binding affinities</title><p id="p0375"><disp-quote><p><inline-graphic xlink:href="fx2.gif"/><bold>Timing: &#x0223c;2 h</bold></p></disp-quote></p><p id="p0380">In this stage, we calculate the binding affinity (&#x00394;G<sub>bind</sub>) of protein-hit and protein-analogs complexes, then compare the differences of binding free energy change (&#x00394;&#x00394;G) between protein-hit and protein-analogs complexes.<list list-type="simple" id="olist0065"><list-item id="o0150"><label>15.</label><p id="p0385">The binding affinity &#x00394;G<sub>bind</sub> can be decomposed into three main energy terms, including the molecular mechanical gas-phase interaction energy (&#x00394;E<sub>MM</sub>), desolvation energy (&#x00394;G<sub>sol</sub>) and the change of conformational entropy (&#x02013;T&#x00394;S). &#x00394;E<sub>MM</sub> and &#x00394;G<sub>sol</sub> are calculated by the MMPBSA module in Amber program. &#x02013;T&#x00394;S is calculated using our in-house scripts. The entropy contribution is temperature-dependent and can be divided to two contributions: solvation entropy (<italic>&#x00394;S</italic><sub><italic>solv</italic></sub>) and conformational entropy (<italic>&#x00394;S</italic><sub><italic>conf</italic></sub>). The solvation entropy consists of the apolar and polar solvation entropy, which is typically given by an empirical formula that is proportional to the apolar and polar solvent accessible surface area differences. We use the <italic>molsurf</italic> and <italic>surf</italic> modules in Amber program to calculate the solvent accessible surface area. The conformational entropy is related to the change of the number of rotatable bonds during the binding process. The change of the conformational entropy is proportional to the number of the lost rotatable bonds during the binding process. The <italic>conf</italic> module in Amber is used to calculate the number of the rotatable bonds. More details can be found in the previous work (<xref rid="bib7" ref-type="bibr">Pan et&#x000a0;al., 2008</xref>). The binding affinity &#x00394;G<sub>bind</sub> for a complex is the average value of 50 structural snapshots.</p></list-item><list-item id="o0155"><label>16.</label><p id="p0390">The binding affinity differences &#x00394;&#x00394;G between the protein-hit and protein-analogs complexes are then obtained as &#x00394;&#x00394;G&#x000a0;= &#x00394;G<sub>bind</sub> (Analogs) &#x02013; &#x00394;G<sub>bind</sub> (Hit).</p></list-item></list></p></sec></sec><sec id="sec4"><title>Expected outcomes</title><p id="p0395"><xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref> illustrates the examples of the expected outcomes of this protocol.<fig id="fig6"><label>Figure&#x000a0;6</label><caption><p>Examples of the expected outcomes of AILDE method</p><p>(A) The calculated binding free energy of the lead compounds with a protein receptor.</p><p>(B) Heatmap showing the activities of the lead compounds obtained by fragment linking. The horizontal axis represents the fragment molecules, and the vertical axis represents the atomic number of the atoms connecting the fragments. The darker the red, the more active the compound is. The darker the blue, the less active the compound is.</p><p>(C) The interaction modes of the lead compounds with protein receptor.</p></caption><graphic xlink:href="gr6"/></fig></p><p id="p0400">We obtain a series of hit analogs from the initial hit molecule. The binding affinity of each analog compound interacting with the protein has been evaluated. Then the binding affinity changes between the protein-analogs and protein-hit complexes are calculated. A negative change of binding free energy indicates an increase in the binding affinity, while a positive change of binding free energy indicates a decrease in the binding affinity. Potential lead compounds are identified based on the rank of the changes of binding free energy. <xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>A shows the results of the binding affinity changes, which contain the information about the analog compound structures, fragment molecules, substituent positions, and binding affinity changes. In addition, a heatmap is plotted to graphically display the relationship between the generated analog compounds and their binding affinity changes (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>B). The horizontal axis represents fragment molecules, and the vertical axis represents hydrogen atoms where the fragment molecules are linked. The darker the red, the more active the compound is. The darker the blue, the less active the compound is. AILDE not only generates the analog compounds, also predict their binding poses in the protein. The binding modes of the compounds interacting with the protein are explored by analyze the complex structures (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>C).</p></sec><sec id="sec5"><title>Limitations</title><p id="p0405">AILDE is based on an assumption that there are no substantial changes in the binding modes between protein-hit and protein-analogs complexes. AILDE could not achieve a good performance in a complicated situation of activity cliffs. This is caused by the compounds with similar structures, but have large differences in binding affinity (<xref rid="bib8" ref-type="bibr">Stumpfe and Bajorath, 2012</xref>). In this protocol, a small fragment library is applied to generate the potential lead compounds. It is suggested to utilize larger chemical space to search and predict more possible lead compounds. The molecular weight of a fragment molecule is recommend to be less than 90 g/mol for a good performance.</p></sec><sec id="sec6"><title>Troubleshooting</title><sec id="sec6.1"><title>Problem 1</title><p id="p0410">AILDE reminders that there are any files not found.</p></sec><sec id="sec6.2"><title>Potential solution</title><p id="p0415">All the input files for AILDE are identified in the parameter file. We should prepare a suitable parameter file according to the example file provided in AILDE source code. We recommend changing the paths of the necessary data file in the example file.</p></sec><sec id="sec6.3"><title>Problem 2</title><p id="p0420">The molecular dynamics simulation terminates abnormally.</p></sec><sec id="sec6.4"><title>Potential solution</title><p id="p0425">We recommend using the protein complex with only one ligand compound as the initial structure to perform the molecular dynamics simulation. In preparing the input structure file of the protein complex with a hit ligand, we could remove the unconcerned chemical compounds in the complex structure.</p></sec><sec id="sec6.5"><title>Problem 3</title><p id="p0430">The structures of the hit analogs generated by fragment growing are weird.</p></sec><sec id="sec6.6"><title>Potential solution</title><p id="p0435">We recommend that the conformational optimization should be performed for the fragment molecules in the step of a fragment library construction. Chimera software could be used to conduct the optimization.</p></sec></sec><sec id="sec7"><title>Resource availability</title><sec id="sec7.1"><title>Lead contact</title><p id="p0440">Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Gefei Hao (<ext-link ext-link-type="uri" xlink:href="mailto:gefei_hao@foxmail.com" id="intref0075">gefei_hao@foxmail.com</ext-link>).</p></sec><sec id="sec7.2"><title>Materials availability</title><p id="p0445">This study did not generate new unique reagents.</p></sec><sec sec-type="data-availability" id="sec7.3"><title>Data and code availability</title><p id="p0450">The online web service of AILDE can be accessed at <ext-link ext-link-type="uri" xlink:href="http://chemyang.ccnu.edu.cn/ccb/server/AILDE" id="intref0080">http://chemyang.ccnu.edu.cn/ccb/server/AILDE</ext-link>. The code of AILDE can be downloaded at <ext-link ext-link-type="uri" xlink:href="https://github.com/fwangccnu/AILDE" id="intref0085">https://github.com/fwangccnu/AILDE</ext-link>.</p></sec></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Benedix</surname><given-names>A.</given-names></name><name><surname>Becker</surname><given-names>C.M.</given-names></name><name><surname>de Groot</surname><given-names>B.L.</given-names></name><name><surname>Caflisch</surname><given-names>A.</given-names></name><name><surname>Bockmann</surname><given-names>R.A.</given-names></name></person-group><article-title>Predicting free energy changes using structural ensembles</article-title><source>Nat. Methods</source><volume>6</volume><year>2009</year><fpage>3</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">19116609</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>G.-F.</given-names></name><name><surname>Yang</surname><given-names>S.-G.</given-names></name><name><surname>Huang</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Shen</surname><given-names>Y.-Q.</given-names></name><name><surname>Tu</surname><given-names>W.-L.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>L.-S.</given-names></name><name><surname>Wu</surname><given-names>J.-W.</given-names></name><name><surname>Berry</surname><given-names>E.A.</given-names></name></person-group><article-title>Rational design of highly potent and slow-binding cytochrome bc1 inhibitor as fungicide by computational substitution optimization</article-title><source>Sci. Rep.</source><volume>5</volume><year>2015</year><fpage>13471</fpage></element-citation></ref><ref id="bib3"><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Hoffer</surname><given-names>L.</given-names></name><name><surname>Voitovich</surname><given-names>Y.V.</given-names></name><name><surname>Raux</surname><given-names>B.</given-names></name><name><surname>Carrasco</surname><given-names>K.</given-names></name><name><surname>Muller</surname><given-names>C.</given-names></name><name><surname>Fedorov</surname><given-names>A.Y.</given-names></name><name><surname>Derviaux</surname><given-names>C.</given-names></name><name><surname>Amouric</surname><given-names>A.</given-names></name><name><surname>Betzi</surname><given-names>S.</given-names></name><name><surname>Horvath</surname><given-names>D.</given-names></name></person-group><article-title>Integrated strategy for lead optimization based on fragment growing: the diversity-oriented-target-focused-synthesis approach</article-title><source>J.&#x000a0;Med. Chem.</source><volume>61</volume><year>2018</year><fpage>5719</fpage><lpage>5732</lpage><pub-id pub-id-type="pmid">29883107</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Irwin</surname><given-names>J.J.</given-names></name><name><surname>Shoichet</surname><given-names>B.K.</given-names></name></person-group><article-title>ZINC--a free database of commercially available compounds for virtual screening</article-title><source>J.&#x000a0;Chem. Inf. Model.</source><volume>45</volume><year>2005</year><fpage>177</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">15667143</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Maximova</surname><given-names>T.</given-names></name><name><surname>Moffatt</surname><given-names>R.</given-names></name><name><surname>Ma</surname><given-names>B.</given-names></name><name><surname>Nussinov</surname><given-names>R.</given-names></name><name><surname>Shehu</surname><given-names>A.</given-names></name></person-group><article-title>Principles and overview of sampling methods for modeling macromolecular structure and dynamics</article-title><source>PLoS Comput. Biol.</source><volume>12</volume><year>2016</year><fpage>e1004619</fpage><pub-id pub-id-type="pmid">27124275</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>X.Y.</given-names></name><name><surname>Zhang</surname><given-names>H.X.</given-names></name><name><surname>Mezei</surname><given-names>M.</given-names></name><name><surname>Cui</surname><given-names>M.</given-names></name></person-group><article-title>Molecular docking: a powerful approach for structure-based drug discovery</article-title><source>Curr. Comput. Aid. Drug Des.</source><volume>7</volume><year>2011</year><fpage>146</fpage><lpage>157</lpage></element-citation></ref><ref id="bib7"><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Gao</surname><given-names>D.</given-names></name><name><surname>Zhan</surname><given-names>C.G.</given-names></name></person-group><article-title>Modeling the catalysis of anti-cocaine catalytic antibody: competing reaction pathways and free energy barriers</article-title><source>J.&#x000a0;Am. Chem. Soc.</source><volume>130</volume><year>2008</year><fpage>5140</fpage><lpage>5149</lpage><pub-id pub-id-type="pmid">18341277</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Stumpfe</surname><given-names>D.</given-names></name><name><surname>Bajorath</surname><given-names>J.</given-names></name></person-group><article-title>Exploring activity cliffs in medicinal chemistry</article-title><source>J.&#x000a0;Med. Chem.</source><volume>55</volume><year>2012</year><fpage>2932</fpage><lpage>2942</lpage><pub-id pub-id-type="pmid">22236250</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Visini</surname><given-names>R.</given-names></name><name><surname>Awale</surname><given-names>M.</given-names></name><name><surname>Reymond</surname><given-names>J.L.</given-names></name></person-group><article-title>Fragment database FDB-17</article-title><source>J.&#x000a0;Chem. Inf. Model.</source><volume>57</volume><year>2017</year><fpage>700</fpage><lpage>709</lpage><pub-id pub-id-type="pmid">28375006</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>F.X.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Yang</surname><given-names>J.F.</given-names></name><name><surname>Jiang</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>M.Y.</given-names></name><name><surname>Jia</surname><given-names>C.Y.</given-names></name><name><surname>Hao</surname><given-names>G.F.</given-names></name><name><surname>Yang</surname><given-names>G.F.</given-names></name></person-group><article-title>AIMMS suite: a web server dedicated for prediction of drug resistance on protein mutation</article-title><source>Brief. Bioinform.</source><volume>21</volume><year>2018</year><fpage>318</fpage><lpage>328</lpage></element-citation></ref><ref id="bib11"><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>F.X.</given-names></name><name><surname>Zhuo</surname><given-names>L.S.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Huang</surname><given-names>W.</given-names></name><name><surname>Hao</surname><given-names>G.F.</given-names></name><name><surname>Yang</surname><given-names>G.F.</given-names></name></person-group><article-title>Auto in&#x000a0;silico ligand directing evolution to facilitate the rapid and efficient discovery of drug lead</article-title><source>iScience</source><volume>23</volume><year>2020</year><fpage>101179</fpage><pub-id pub-id-type="pmid">32498019</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.F.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Jiang</surname><given-names>W.</given-names></name><name><surname>Zhou</surname><given-names>G.Y.</given-names></name><name><surname>Li</surname><given-names>C.Z.</given-names></name><name><surname>Zhu</surname><given-names>X.L.</given-names></name><name><surname>Hao</surname><given-names>G.F.</given-names></name><name><surname>Yang</surname><given-names>G.F.</given-names></name></person-group><article-title>PADFrag: a database built for the exploration of bioactive fragment space for drug discovery</article-title><source>J.&#x000a0;Chem. Inf. Model.</source><volume>58</volume><year>2018</year><fpage>1725</fpage><lpage>1730</lpage><pub-id pub-id-type="pmid">30134653</pub-id></element-citation></ref></ref-list><ack id="ack0010"><title>Acknowledgments</title><p id="p0460">This work was supported by the <funding-source id="gs2"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source> (21772059, 91853127, and 31960548), Program of Introducing Talents of Discipline to Universities of China (<funding-source id="gs3">111 Program</funding-source>, D20023), and Frontiers Science Center for Asymmetric Synthesis and Medicinal Molecules, <funding-source id="gs4"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100010828</institution-id><institution>Department of Education, Guizhou Province</institution></institution-wrap></funding-source> (Qianjiaohe KY number (2020)004).</p><sec id="sec9"><title>Author contributions</title><p id="p0465">Conceptualization, G.H.; programming, F.W.; writing &#x02013; original draft, L.M. and F.W.; writing &#x02013; review &#x00026; editing, G.H. and G.Y.</p></sec><sec sec-type="COI-statement" id="sec10"><title>Declaration of interests</title><p id="p0470">The authors declare no competing interests.</p></sec></ack></back></article>